Teva Pharmaceutical Industries (TEVA) Revenue Growth (1y) (2010 - 2026)
Teva Pharmaceutical Industries (TEVA) Revenue Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.10 Bn | 20.95 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 14.92% |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | 333.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.34% |
| Dec 31, 2025 | 62.45% |
| Sep 30, 2025 | 3.42% |
| Jun 30, 2025 | 0.29% |
| Mar 31, 2025 | 1.89% |
| Dec 31, 2024 | -34.93% |
| Sep 30, 2024 | 12.52% |
| Jun 30, 2024 | 7.37% |
| Mar 31, 2024 | 4.32% |
| Dec 31, 2023 | 14.75% |
| Sep 30, 2023 | 7.09% |
| Jun 30, 2023 | 2.43% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -5.27% |
| Sep 30, 2022 | -7.51% |
| Jun 30, 2022 | -3.17% |
| Mar 31, 2022 | -8.06% |
| Dec 31, 2021 | -7.95% |
| Sep 30, 2021 | -2.29% |
| Jun 30, 2021 | 1.03% |